The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2024

Filed:

Jul. 12, 2019
Applicant:

H. Lundbeck A/s, Valby, DK;

Inventors:

Brian Baker, Kirkland, WA (US);

Jeffrey T.L. Smith, Bellevue, WA (US);

John Latham, Seattle, WA (US);

Assignee:

H. LUNDBECK A/S, Valby, DK;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/00 (2006.01); C07K 16/26 (2006.01); G01N 33/50 (2006.01); G01N 33/66 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); G01N 33/5038 (2013.01); G01N 33/5088 (2013.01); G01N 33/66 (2013.01); A61K 2039/505 (2013.01); C07K 16/26 (2013.01); C07K 2317/76 (2013.01); G01N 2333/5753 (2013.01);
Abstract

The present disclosure provides methods for the prevention or treatment of metabolic disorders. In exemplary embodiments, methods of administering an anti-CGRP antibody are provided, optionally in combination with a second agent, wherein peripheral and/or hepatic glucose utilization is increased, thereby preventing or treating diseases and disorders associated with insulin resistance. Compositions comprising an anti-CGRP antibody are also provided, optionally in combination with a second agent, which are suitable for administration to increase peripheral and/or hepatic glucose utilization and thereby prevent or treat diseases and disorders associated with insulin resistance.


Find Patent Forward Citations

Loading…